PP Nawroth
Impact in
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
-
- Natural Antidiabetic Agents Studies
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Advanced Glycation End Products research 8
-
- Venous Thromboembolism Diagnosis and Management 4
- Co-authors
- Hans TritschlerGeorge L. KingLester PackerAngelika BierhausGottfried RudofskyKL KaplanH. L. NosselE. Schleicher
- Journals
- Experimental and Clinical Endocrinology & Diabetes (11 papers)Blood (3 papers)Clinical Transplantation (2 papers)Hormone and Metabolic Research (2 papers)Clinical Nephrology (1 paper)
- Partner nations
- GermanyUnited StatesRussia
In The Last Decade
PP Nawroth
40 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Clinical Biochemistry 293
- Endocrinology, Diabetes and Metabolism 378
- Biochemistry 101
- Physiology 344
- Biochemistry 79
Countries citing papers authored by PP Nawroth
This map shows the geographic impact of PP Nawroth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PP Nawroth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PP Nawroth more than expected).
Fields of papers citing papers by PP Nawroth
This network shows the impact of papers produced by PP Nawroth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PP Nawroth. The network helps show where PP Nawroth may publish in the future.
Co-authorship network
The 25 scholars most cited alongside PP Nawroth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 1 | |
| 2 | 2012 | 27 | |
| 3 | 2011 | 4 | |
| 4 | 2011 | 25 | |
| 5 | 2010 | 2 | |
| 6 | 2009 | 15 | |
| 7 | 2009 | 5 | |
| 8 | 2009 | 21 | |
| 9 | 2009 | 5 | |
| 10 | 2008 | 3 | |
| 11 | 2007 | 12 | |
| 12 | Glycotoxins and cellular dysfunction. A new mechanism for understanding the preventive effects of lifestyle modifications | 2006 | 2 |
| 13 | 2004 | 48 | |
| 14 | 2004 | 22 | |
| 15 | 2001 | 0 | |
| 16 | Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus. | 1996 | 26 |
| 17 | [Successful use of a heparinoid (danaparoid sodium) for heparin-induced thrombocytopenia type II in aortic valve reoperation]. | 1995 | 5 |
| 18 | 1992 | 21 | |
| 19 | 培養内皮細胞でプレプロエンドセリン、組織因子、癌原遺伝子の転写を増強する腫瘍壊死因子カケクチン | 1991 | 2 |
| 20 | [Regulation of the endothelium by TNF]. | 1991 | 1 |
About PP Nawroth
PP Nawroth is a scholar working on Clinical Biochemistry, Internal Medicine, Transplantation, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, having authored 44 papers that have together received 1.3k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (8 papers), Diet and metabolism studies (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Metabolism, Diabetes, and Cancer (3 papers), Neurological Disorders and Treatments (3 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Clinical Biochemistry (293 citations), Endocrinology, Diabetes and Metabolism (378 citations), Biochemistry (101 citations), Physiology (344 citations) and Biochemistry (79 citations). PP Nawroth has collaborated with scholars based in Germany, United States and Russia. Frequent co-authors include Hans Tritschler, George L. King, Lester Packer, Angelika Bierhaus, Gottfried Rudofsky, KL Kaplan, H. L. Nossel, E. Schleicher, A. Hamann and M. Haslbeck. Their work appears in journals such as Experimental and Clinical Endocrinology & Diabetes, Blood, Clinical Transplantation, Hormone and Metabolic Research and Clinical Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.